The Latest “Behind the Buzz” Show: Featuring Canopy Rivers Inc. (TSX-V: RIV) (OTC: CNPOF) Corporate Overview

Published on: 06 May, 2019’s latest Behind the Buzz Show: Featuring Our Corporate Overview on Canopy Rivers Inc.

Canopy Rivers Inc. (TSX-V: RIV) (OTC: CNPOF) is a unique investment and operating platform structured to pursue opportunities in the emerging global cannabis sector. The Company is managed by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks; but what makes Canopy Rivers truly unique is the Company’s strategic partnership and cornerstone investment from Canopy Growth Corporation (TSX: WEED) (NYSE: CGC).

Canopy Rivers works collaboratively with Canopy Growth to identify strategic counterparties seeking financial and/or operating support and affiliation with the Canopy Growth group of companies. The result is an ecosystem of complementary companies operating throughout the cannabis value chain. As the portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves, which the company believes results in an ideal environment for innovation, synergy, and value creation for Canopy Rivers, Canopy Growth, and across the entire Rivers ecosystem.

As cannabis use continues to become increasingly mainstream, consumers are beginning to wonder where the industry is headed. While it still remains an illicit drug under the Single Convention of Narcotic Drugs, there is a clear distinction between cannabis for recreational, medical, and scientific research purposes. While recreational use is strictly prohibited around the globe, many countries are largely only permitting cannabis use for medical and scientific purposes. Nevertheless, Canada and Uruguay have already legalized cannabis entirely, with Canada becoming the first G-7 nation to do so. Additionally, most of the other G-7 nations have since adopted cannabis legislation of some sort since, as, among the other G-7 nations, France, Germany, Italy, the U.K., and the U.S. have all implemented partial or complete medicinal cannabis programs. In particular, the U.S. has seen political tides shift over recent years as the consumer perspective on cannabis continues to change. In 2018, over 62% of Americans supported the legalization of cannabis, which has more than doubled in the past two decades, according to Pew Research Center. The overwhelming support has also recently led to the legalization of cannabis in Missouri, Michigan, and Utah during the U.S. midterm elections in late 2018. The addition of these three states now brings the total to 33 states, including the District of Columbia, which have legalized cannabis on a certain level. The U.S. alone is expected to be the primary growth driver for the global cannabis market because of states such as California, Colorado, Nevada, and Washington, which are expected to deliver billions of dollars in revenue, collectively. According to data compiled by Mordor Intelligence, the global cannabis market was valued at USD 7.7 Billion and is expected to reach USD 65 Billion by 2023. Additionally, the market is projected to grow at a CAGR of 37% throughout the forecast period from 2018 to 2023.

In the near future, states such as New Jersey, New York, Illinois, Connecticut, New Mexico are all likely candidates to legalize cannabis. Additionally, some states like Rhode Island, Kansas, Wisconsin, and Pennsylvania are also exploring opportunities within the industry. And, on a more global scale, Mexico’s newly elected President is pushing for the country’s legalization of cannabis while European nations Switzerland and the United Kingdom are seeing growing support for complete legalization as well. Predominantly, the global cannabis market revenue is driven by the medical segment, however, data suggests that there could be a shift in the market share in the coming years. Arcview Market Research and BDS Analytics’ research suggests that legal cannabis sales are expected to reach USD 57 Billion by 2027. Furthermore, the research suggests that adult-use sales are expected to account for USD 38.3 Billion of the legal spending, while medical sales account for USD 19.1 Billion. In particular, the North American region’s recreational cannabis industry is expected to dominate, as the maturing markets are seeing growing spending numbers from consumers. Additionally, the region’s growth is also set to entice other countries, eventually leading to a more robust, global growth of the market. “The industry is at about 5 percent of what it will be someday,” concurs Tyler Stratford, Director of Client Operations for cannabis consulting firm Canna Advisors. “Even if the path forward isn’t straight, we’re certainly on a path forward. The tide has changed, and there’s no turning it back now.”

For more information, please visit: Canopy Rivers Inc.

About Behind the Buzz: One of’s latest corporate and financial news shows, covering the latest trending stock market news. Behind the Buzz looks to become a leader in corporate video news dissemination. Behind the Buzz is 100% original content, brought to you by Financial Buzz Media.


  • 2485Views
  • 0Comments

Recommend to Friends

  • facebook
  • Twitter
  • google plus
  • pinterest
  • Digg
  • stumbleupon
  • Reddit
  • linkedin

Nikita Medvedev



Sign Up for Weekly Updates

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!

Related Posts

07 Jul, 2017 3051
16 Aug, 2017 2990
21 Sep, 2017 2567
29 Sep, 2017 5427


There is no comment on this article